Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jia-Lin Meng (Jialin Meng)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 25

Top Venues

Clinical and translational medicine

The Prostate

Journal of cellular and molecular medicine

Cancer medicine

University of Rochester Medical Center

First Affiliated Hospital of Anhui Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Rochester Medical Center Apr 1o 2018 - Jul 31o 2020

United States

Visiting Post-doctoral Fellow :: Departments of Urology and Pathology

Education History

First Affiliated Hospital of Anhui Medical University Sep 7o 2018

China

PHD :: Urology

Publications

Meng Zhang, Zichen Bian, Jia Chen, Lei Chen, Jun Zhou, Qingsong Niu, Zongyao Hao, Jia-Lin Meng, Chao-Zhao Liang
In silico validation of a new classifier, PCSCG ier , for predicting recurrence-free survival in prostate cancer patients: Evidence from multiple datasets. Clinical and translational medicine 13 (1) (2023)
Meng Zhang, Zichen Bian, Jia Chen, Lei Chen, Jun Zhou, Qingsong Niu, Zongyao Hao, Jia-Lin Meng, Chao-Zhao Liang
In silico validation of a new classifier, PCSCG ier , for predicting recurrence-free survival in prostate cancer patients: Evidence from multiple datasets. Clinical and translational medicine 13 (1) (2023)
Meng Zhang, Zichen Bian, Jia Chen, Lei Chen, Jun Zhou, Qingsong Niu, Zongyao Hao, Jia-Lin Meng, Chao-Zhao Liang
In silico validation of a new classifier, PCSCG ier , for predicting recurrence-free survival in prostate cancer patients: Evidence from multiple datasets. Clinical and translational medicine 13 (1) (2023)
Yongtao Hu, Qiao Qi, Yongshun Zheng, Haoran Wang, Jun Zhou, Zongyao Hao, Jia-Lin Meng, Chao-Zhao Liang
Nomogram for predicting the overall survival of patients with early-onset prostate cancer: A population-based retrospective study. Cancer medicine 11 (17) (2022)
Xiaofan Lu, Jia-Lin Meng, Junkai Zhu, Yujie Zhou, Liyun Jiang, Yang Wang, Weiheng Wen, Chaozhao Liang, Fangrong Yan
Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair-based signature. Clinical and translational medicine 11 (6) (2022)
Meng Zhang, Chen Jin, Yang Ding, Yuqing Tao, Yulin Zhang, Ziyue Fu, Tao Zhou, Li Zhang, Zhengyao Song, Zong-Yao Hao, Jia-Lin Meng, Chaozhao Liang
Higher Intake of Fat, Vitamin E-(β+γ), Magnesium, Sodium, and Copper Increases the Susceptibility to Prostatitis-like Symptoms: Evidence from a Chinese Adult Cohort. Nutrients 14 (18) (2022)
Chenghao Wen, Qintao Ge, Bangshun Dai, Jiawei Li, Feixiang Yang, Jia-Lin Meng, Shenglin Gao, Song Fan, Li Zhang
Signature for Prostate Cancer Based on Autophagy-Related Genes and a Nomogram for Quantitative Risk Stratification. Disease markers 2022 (2022)
Jia-Lin Meng, Xiaofan Lu, Chen Jin, Yujie Zhou, Qintao Ge, Jun Zhou, Zongyao Hao, Fangrong Yan, Meng Zhang, Chaozhao Liang
Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer. Clinical and translational medicine 11 (12) (2022)
Qing Liu, Bosen You, Jia-Lin Meng, Chi-Ping Huang, Guanglu Dong, Ronghao Wang, Fuju Chou, Shan Gao, Chawnshang Chang, Shuyuan Yeh, Wanhai Xu
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling. Cancer gene therapy (2022)
Jia-Lin Meng, Yu Guan, Bijun Wang, Lei Chen, Junyi Chen, Meng Zhang, Chao-Zhao Liang
Risk subtyping and prognostic assessment of prostate cancer based on consensus genes. Communications biology 5 (1) (2022)
Jing Chen, Jia-Lin Meng, Yi Liu, Zichen Bian, Qingsong Niu, Junyi Chen, Jun Zhou, Li Zhang, Meng Zhang, Chao-Zhao Liang
Establishment of a five-enzalutamide-resistance-related-gene-based classifier for recurrence-free survival predicting of prostate cancer. Journal of cellular and molecular medicine 26 (21) (2022)
Xiaofan Lu, Jia-Lin Meng, Liwen Su, Liyun Jiang, Haitao Wang, Junkai Zhu, Mengjia Huang, Wenxuan Cheng, Li Xu, Xinjia Ruan, Shuyuan Yeh, Chaozhao Liang, Fangrong Yan
Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies. Clinical and translational medicine 11 (12) (2022)
Jing Chen, Jia-Lin Meng, Chen Jin, Fan Mo, Yang Ding, Xiaomei Gao, Li Zhang, Meng Zhang, Chao-Zhao Liang
4-Methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy for chronic prostatitis. The Prostate 81 (14) (2021)
Yu-Jie Zhou, Xiao-Fan Lu, Jia-Lin Meng, Qi-Wen Wang, Jin-Nan Chen, Qing-Wei Zhang, Kenneth I Zheng, Claudia S Rocha, Carla B Martins, Fang-Rong Yan, Xiao-Bo Li
Specific epigenetic age acceleration patterns among four molecular subtypes of gastric cancer and their prognostic value. Epigenomics 13 (10) (2021)
Yi Liu, Yong Zhang, Meng Zhang, Jia-Lin Meng, Qingqing Ma, Zongyao Hao, Meijuan Zheng, Li Zhang, Xianguo Chen, Chao-Zhao Liang
Activated autophagy restored the impaired frequency and function of regulatory T cells in chronic prostatitis. The Prostate 81 (1) (2020)
Xinjia Ruan, Xiaofan Lu, Jun Gao, Liyun Jiang, Yue Zhu, Yu-Jie Zhou, Jia-Lin Meng, Hangyu Yan, Fangrong Yan, Fei Wang
Multiomics data reveals the influences of myasthenia gravis on thymoma and its precision treatment. Journal of cellular physiology 236 (2) (2020)
Yu Liu, Yiding Chen, Xianyu Hu, Jia-Lin Meng, Xiao-Jing Li
Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma. BioMed research international 2020 (2020)
Jia-Lin Meng, Xiaofan Lu, Yujie Zhou, Meng Zhang, Lei Gao, Shenglin Gao, Fangrong Yan, Chao-Zhao Liang
Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer. Journal of cellular and molecular medicine 24 (10) (2020)
Keliang Wang, Jie Luo, Shuyuan Yeh, Bosen You, Jia-Lin Meng, Philip Chang, Yuanjie Niu, Gonghui Li, Changxue Lu, Yezi Zhu, Emmanuel S Antonarakis, Jun Luo, Chi-Ping Huang, Wanhai Xu, Chawnshang Chang
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nature communications 11 (1) (2020)
Jia-Lin Meng, Yujie Zhou, Xiaofan Lu, Zichen Bian, Yiding Chen, Jun Zhou, Li Zhang, Zongyao Hao, Meng Zhang, Chaozhao Liang
Immune response drives outcomes in prostate cancer: implications for immunotherapy. Molecular oncology 15 (5) (2020)
Jia-Lin Meng, Lei Gao, Meng Zhang, Shenglin Gao, Song Fan, Chaozhao Liang
Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients. Biomarkers in medicine 14 (3) (2020)
Jia-Lin Meng, Yi Liu, Shi-Yang Guan, Song Fan, Jun Zhou, Meng Zhang, Chaozhao Liang
The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer. Cancer medicine 8 (11) (2019)
Jia-Lin Meng, Yi Liu, Shi-Yang Guan, Huiya Ma, Xiaoyu Zhang, Song Fan, Huaqing Hu, Meng Zhang, Chaozhao Liang
Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: Evidence from 5285 patients. International journal of clinical practice (2019)
Jia-Lin Meng, Meng Zhang, Shi-Yang Guan, Jun Zhou, Song Fan, Huaqing Hu, Chao-Zhao Liang
The prevalence and risk factors of prostatic calculi in Han Chinese: a cross-sectional study based on health examinations. The aging male : the official journal of the International Society for the Study of the Aging Male 23 (5) (2019)
Haoran Xia, Yiding Chen, Jia-Lin Meng, Chaozhao Liang
Effect of polymorphism on IL1A to cancer susceptibility: Evidence based on 34,016 subjects. Artificial cells, nanomedicine, and biotechnology 47 (1) (2019)

Jia-Lin Meng.css-eqlu8i{font-size:small;padding-left:4px;} (Jialin Meng)

Publication Activity (10 Years)

Top Topics

Top Venues

Jia-Lin Meng (Jialin Meng)